Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development

The need for solid clinical definitions of resistance to programmed death 1 or its ligand (PD-(L)1) inhibitors for clinical trial design was identified as a priority by the Society for Immunotherapy of Cancer (SITC). Broad consensus efforts have provided definitions for primary and secondary resista...

Descripción completa

Detalles Bibliográficos
Autores principales: Tawbi, Hussein A, Sullivan, Ryan J, Feltquate, David, LaVallee, Theresa, Rizvi, Naiyer A, Sharon, Elad, Sosman, Jeffrey, Kluger, Harriet M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373737/
https://www.ncbi.nlm.nih.gov/pubmed/37487665
http://dx.doi.org/10.1136/jitc-2023-007309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373737/
https://www.ncbi.nlm.nih.gov/pubmed/37487665
http://dx.doi.org/10.1136/jitc-2023-007309

Ejemplares similares